OBJECTIVES: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with
increasing disability, reduced quality of life and substantial costs (as a result of both …

Data from several different monitoring systems are examined. The potential for registers
based on data obtained from clinical practice, and linkage of such data to national health …

Background The inflammatory contribution to type 2 diabetes (T2D) has suggested new
therapeutic targets using biologic drugs designed for rheumatoid arthritis (RA). On this basis …

Background The effects of fish oil (FO) in rheumatoid arthritis (RA) have not been examined
in the context of contemporary treatment of early RA. This study examined the effects of high …

Abstract Objective Randomized clinical trials (RCTs) evaluate the efficacy of treatments in
selected groups of patients defined by strict inclusion criteria. The value of these trials in …

Objective. To identify factors predicting response to first TNF blocking treatment course in
patients with established RA with a special focus on gender differences. Methods. Patients …

The objective of this work is to compare the adherence to therapy of patients receiving
etanercept and infliximab during first tumour necrosis factor (TNF)-blocking treatment course …

Objective To describe the use of the LUNDEX, a new index for comparing the long‐term
efficacy and tolerability of biologic therapies in rheumatoid arthritis (RA) patients treated in …

Objective To investigate whether patients with RA enrolled in randomized controlled trials
(RCTs) and observational studies may differ in terms of characteristics that could modify …

Objective Despite advances in rheumatoid arthritis (RA) treatment, patients' decisions
regarding therapy often deviate from expert recommendation. This study was undertaken to …